We are live on
!
Find out more
Eli Lilly
1,559 hedge funds and large institutions have $94.2B invested in Eli Lilly in 2018 Q4 according to their latest regulatory filings, with 229 funds opening new positions, 453 increasing their positions, 595 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.95% more ownership
Funds ownership: 77.07% → 78.02% (+0.95%)
7% less call options, than puts
Call options by funds: $739M | Put options by funds: $797M
24% less repeat investments, than reductions
Existing positions increased: 453 | Existing positions reduced: 595
Holders
1,559
Holding in Top 10
62
Calls
$739M
Puts
$797M
Top Buyers
| 1 | +$1.59B | |
| 2 | +$697M | |
| 3 | +$419M | |
| 4 |
BlackRock
New York
|
+$227M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$178M |
Top Sellers
| 1 | -$1.17B | |
| 2 | -$814M | |
| 3 | -$803M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$468M |
| 5 |
BGC
Beutel, Goodman & Co
Toronto,
Ontario, Canada
|
-$180M |